What is the likely cause of a single or bilateral enlarged nipple in a 13‑year‑old male and how should it be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Enlarged Nipple in a 13-Year-Old Male

This is almost certainly physiologic pubertal gynecomastia, which is a normal finding in up to 50% of adolescent males at this age and requires no imaging or treatment—only reassurance. 1, 2

What This Likely Is

Pubertal gynecomastia is benign breast tissue enlargement that typically appears at ages 13-14 years due to temporary hormonal imbalances between estrogen and androgen during puberty. 2, 3 The condition presents as:

  • A soft, rubbery, or firm mobile mass directly under the nipple 1
  • Often tender or painful, especially in the first 6 months 1
  • Bilateral in approximately 50% of cases (unilateral is also completely normal) 1
  • Self-limited, resolving spontaneously in 75-90% of adolescents over 1-3 years 3, 4

No Imaging or Testing Needed

For a 13-year-old with clinical findings consistent with gynecomastia, no imaging is routinely recommended. 1 The American College of Radiology explicitly states that unnecessary imaging in clear cases of gynecomastia leads to additional unnecessary benign biopsies without improving outcomes. 1

Most adolescent males with breast symptoms can be diagnosed based on clinical findings alone without any imaging. 1

When to Consider Further Evaluation

Imaging (ultrasound for boys under 25) is only indicated if: 1

  • The mass is hard, fixed, or eccentric (off to the side rather than directly under the nipple)
  • There is bloody nipple discharge
  • There is skin or nipple retraction
  • The differentiation between benign disease and breast cancer cannot be made clinically

Important caveat: Male breast cancer is extremely rare in adolescents—the median age is 63 years. 1

Management Algorithm

Step 1: Reassurance (Standard of Care)

Reassurance remains the standard of care for physiologic gynecomastia in adolescents. 2 Explain that:

  • This is a normal part of puberty affecting up to 50% of boys 2, 5
  • It will likely resolve on its own within 1-3 years 3, 4
  • No treatment is medically necessary 2

Step 2: Address Psychological Impact

Gynecomastia commonly causes significant psychological stress, embarrassment, and depression in adolescents. 3, 6 Assess the emotional impact and provide appropriate support. 2

Step 3: Observation Period

Monitor for spontaneous resolution over the next 1-3 years. 3 Up to 50% of cases with non-cyclical breast symptoms resolve spontaneously. 1

Step 4: Consider Medical Therapy (Only If Persistent Beyond 12 Months AND Causing Substantial Distress)

If gynecomastia persists beyond 12 months and causes substantial tenderness or embarrassment, pharmacological therapy may be considered: 3, 6

  • Tamoxifen (a selective estrogen receptor modulator) is the most studied and effective medication, found to be safe with minimal side effects 6
  • Pharmacological therapy is most effective when given early in the course and works best for small to moderate breast enlargement 3
  • Important limitation: Neither tamoxifen nor other medications are universally FDA-approved for gynecomastia treatment because risks and benefits have not been completely studied 3

Step 5: Surgical Referral (Reserved for Severe Cases)

Surgery is reserved for severe cases causing significant psychological distress and is typically offered towards the end of puberty after allowing time for spontaneous resolution. 6

What to Rule Out (History Taking)

Ask specifically about: 2, 4

  • Medications: Anabolic-androgenic steroids, spironolactone, ketoconazole, finasteride, or other drugs 7, 2
  • Illicit substances: Cannabis use (especially chronic use started at young age) 7, 2
  • Herbal products or supplements 2
  • Testicular examination findings: Check for masses or abnormalities that might suggest hormone-secreting tumors 1

Common Pitfalls to Avoid

  • Do not order imaging for typical pubertal gynecomastia—this leads to unnecessary biopsies and anxiety 1
  • Do not confuse true gynecomastia with pseudogynecomastia (fatty tissue in overweight boys), though both are benign 1
  • Do not rush to pharmacological treatment—most cases resolve spontaneously and medications lack full FDA approval for this indication 3, 6
  • Do not dismiss the psychological impact—assess and address emotional distress even when reassuring about the benign nature 2, 3

References

Guideline

Gynecomastia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Gynecomastia in adolescents.

Current opinion in pediatrics, 2008

Research

Management of Adolescent Gynecomastia: An Update.

Acta bio-medica : Atenei Parmensis, 2017

Research

Gynecomastia.

American family physician, 2012

Research

Endocrine Hormones and Their Impact on Pubertal Gynecomastia.

Journal of clinical medicine, 2024

Guideline

Iatrogenic Causes of Gynecomastia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the initial approach to managing gynecomastia in adolescent males?
What is the recommended management for a 46-year-old male patient with bilateral minimal benign gynecomastia?
What is the best course of action for a 46-year-old male patient with minimal benign gynecomastia (enlargement of breast tissue in males) and no suspicious findings?
What is the approach to endocrine evaluation in adolescent gynaecomastia?
How does SERM (Selective Estrogen Receptor Modulator) treat gynecomastia?
What is the appropriate starting dose and titration schedule for Abilify (aripiprazole) in an adult patient, and how should the dose be adjusted for elderly individuals or those with hepatic impairment?
What are the dosing, administration, contraindications, side effects, and monitoring recommendations for Abilify Maintena (aripiprazole) in adults for maintenance treatment of schizophrenia and bipolar I disorder?
Does a patient with full‑blown manic episodes (extreme highs) and major depressive episodes (extreme lows) have bipolar I disorder or bipolar II disorder?
How should I manage a 13‑day post‑allogeneic bone marrow transplant patient with aplastic anemia who has profound neutropenia, severe thrombocytopenia, persistent fever, markedly elevated procalcitonin, acute kidney injury, diarrhea, acute abdomen, and has been NPO for a week due to vomiting and hematemesis?
How should I initiate long‑acting aripiprazole (Abilify Maintena) in a patient, including oral overlap and loading dose considerations?
How much should I reduce the levothyroxine dose for a 47‑year‑old woman taking 200 µg daily with a markedly suppressed thyroid‑stimulating hormone (TSH) of 0.02 mU/L?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.